Results 151 to 160 of about 14,833,612 (178)

Structural elucidation of metabolites of tanshinone I and its analogue dihydrotanshinone I in rats by HPLC–ESI-MSn

Journal of Chromatography B, 2010
Tanshinone I and its analogue dihydrotanshinone I are the major active components isolated from Salvia miltiorrhiza Bunge and Salvia Przewalskii Maxim. These compounds have been found to possess significant antibacterial, anti-dermatophytic, antioxidant, anti-inflammatory and anticancer activities.
Mingming, Wang, Haixue, Dai, Xiaorong, Li, Yuhang, Li, Lijuan, Wang, Ming, Xue   +5 more
openaire   +2 more sources

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis

Biochemical Pharmacology, 2007
Chemotherapeutic drugs are usually designed to induce cancer cell death via cell cycle arrest and/or apoptosis pathways. In this study, we used the chemical drug 15,16-dihydrotanshinone I (DHTS) to inhibit breast cancer cell proliferation and tumor growth, and investigate the underlying molecular mechanisms. Human breast cancer cell lines MCF-7 and MDA-
Sun-Lung, Tsai, Fat-Moon, Suk, Chun-I, Wang, Der-Zen, Liu, Wen-Chi, Hou, Pei-Jung, Lin, Ling-Fang, Hung, Yu-Chih, Liang   +7 more
openaire   +2 more sources

15,16-Dihydrotanshinone I-induced apoptosis in human colorectal cancer cells: involvement of ATF3.

Anticancer research, 2013
15,16-Dihydrotanshinone I (DHTS) is a component of the traditional Chinese medicinal plant Salvia miltiorrhiza Bunge. In this study, DHTS at as low as 2.5 μg/ml concentration significantly inhibited proliferation of human benign (SW480) and malignant (SW620) colorectal cancer cells, as shown by 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5 ...
Fat-Moon, Suk, Wen-Ju, Jou, Ren-Jye, Lin, Shyr-Yi, Lin, Fang-Yu, Tzeng, Yu-Chih, Liang   +5 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Dihydrotanshinone I attenuates cisplatin-induced acute kidney injury by targeting TRIM28-mediated oxidative stress and apoptosis: insights from activity-based protein profiling and omics integration

Rare Metals
Pingping Sun, Jun Sun, Ze Li, Jing Chang, Mei-Ling Jin, Jiayu Song, Qianmei Sun, Xiao-Juan Wang   +7 more
semanticscholar   +1 more source

Danhong Injection targets CaMKII through Dihydrotanshinone I to alleviate cardiomyocyte death and inflammation in viral myocarditis.

Science China Life Sciences
Junxia Zhang, Chengcheng Zhao, Wenjia Zhang, Mao Zhang, Fan Li, Haibao Shang, Wen Zheng, Yingjia Li, Li Quan, Xiaochuan Li, Huihui Li, Luyun Wang, Zheng Wen, Yiwu Zhou, Dao Wen Wang, Erdan Dong, Chen Chen, Yan Zhang   +17 more
semanticscholar   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Preparation of AuSe-BNPs/CFME and its high-sensitivity simultaneous detection of caffeic acid and dihydrotanshinone I

Chemical Engineering Journal
Han Cheng, Yanbing Pan, Tao Fang, U. Ishimov, A. Ihsan, Abrar Hussain, Ruiting Tian, Wenwen Ma, Jun Li, Xianju Huang   +9 more
semanticscholar   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly